MOSCOW, Nov 28 (PRIME) -- Pharmaceutical company Binnopharm has not abandoned plans to hold an initial public offering (IPO) in Russia, CEO Rustem Muratov said on Monday.
"We are not only considering the Asian markets, but are not abandoning a plan to place shares in Russia, it will depend on the state of the Russian market," Muratov said.
The official said that the investment climate in the country may soon recover, including for retail clients, while he sees Binnopharm as an asset attractive for many investors.
End
|
|
